The effective shelf enables immediate selling by private placement holders, likely creating persistent downward pressure. Monitor for any takedown notices or Form 4 filings from selling stockholders. The going concern opinion amplifies risk — any sales could accelerate a death spiral.
Price Chart
Executive Summary
Traws Pharma's S-3 shelf registration (File No. 333-295727) became effective on May 15, 2026, enabling selling stockholders to resell up to 35,897,514 shares from an April 2026 private placement. The company receives no proceeds, and the audit report includes a going concern opinion, creating a massive potential overhang of 237% of current shares outstanding.
Key Facts
- S-3 shelf registration effective May 15, 2026, covering 35,897,514 shares for resale by selling stockholders
- Company receives no proceeds from any sales under this shelf
- Audit report includes a going concern opinion
- Potential overhang equals approximately 237% of current shares outstanding
- Stock trading below warrant exercise price, increasing dilution risk
Financial Impact
Potential dilution of 237% of current shares outstanding; no proceeds to company
Risk Factors
- Massive dilution from up to 35.9M shares hitting the market
- Going concern opinion signals potential insolvency risk
- No cash inflow to offset dilution — pure overhang
- Stock below warrant exercise price may trigger further dilution if warrants are exercised
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| EFFECT Filing (Primary) | 9999999995-26-001674 |
| Document: 9999999995-26-001674-index.html | 9999999995-26-001674 |
| Document: 9999999995-26-001674.txt | 9999999995-26-001674 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 26, 2026 today | S-1 | $0.3500 | awaiting T+20 | — | $0.3391 (+3.11%) |
Oct 23, 2026 3d ago | 8-K | $0.3510 | awaiting T+20 | — | $0.3391 (+3.39%) |
Oct 20, 2026 6d ago | DEFA14A | $0.3760 | awaiting T+20 | — | $0.3391 (−9.81%) |
Oct 20, 2026 6d ago | DEF 14A | $0.3760 | awaiting T+20 | — | $0.3391 (+9.81%) |
Aug 14, 2026 10w ago | Press Release | $0.5400 $0.5200 | ▲ +3.70% | ▲ +2.18% | $0.3391 (+37.20%) |
Jul 10, 2026 15w ago | 8-K | $0.6849 $0.5400 | ▲ +21.16% | ▲ +24.34% | $0.3391 (+50.49%) |
Jul 10, 2026 15w ago | 424B5 | $0.6849 $0.5400 | ▲ +21.16% | ▲ +24.34% | $0.3391 (+50.49%) |
Jul 10, 2026 15w ago | EFFECT | $0.7600 $0.5320 | ▲ +30.00% | ▲ +32.43% | $0.3391 (+55.38%) |
Jul 9, 2026 15w ago | 8-K | $0.7600 $0.5320 | ▼ −30.00% | ▼ −32.43% | $0.3391 (−55.38%) |
Jul 1, 2026 16w ago | S-3 | $0.7677 $0.4411 | ▼ −42.54% | ▼ −42.13% | $0.3391 (−55.83%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers